跳至主要内容
临床试验/NCT03157050
NCT03157050已完成不适用

Intravenous Iron May Increase Depression Among Hemodialysis Patients

Benha University0 个研究点目标入组 112 人开始时间: 2016年1月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
112
主要终点
Change in patient health questionnaire-9 score

研究概览

简要总结

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age was above 19 years,
  • patient on maintenance hemodialysis,
  • patient had iron deficiency anemia (ferritin > 100 ng/ml)

排除标准

  • patient has history of depression or already using antidepressant medication,
  • Lack of ferritin level increase ≥ 50% from baseline level before IV iron administration,
  • patient already on oral or intravenous iron supplement

结局指标

主要结局

Change in patient health questionnaire-9 score

时间窗: on day 0 of start of intravenous iron and 1 week after completion of intravenous iron

change in patient health questionnaire-9 score before and after intravenous iron therapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahmoud Hamada imam

Lecturer of Internal Medicine - Faculty of Medicine

Benha University

相似试验